Display options
Share it on

Expert Opin Drug Discov. 2015;10(9):975-89. doi: 10.1517/17460441.2015.1061991. Epub 2015 Jul 15.

X-ray crystallography over the past decade for novel drug discovery - where are we heading next?.

Expert opinion on drug discovery

Heping Zheng, Katarzyna B Handing, Matthew D Zimmerman, Ivan G Shabalin, Steven C Almo, Wladek Minor

Affiliations

  1. University of Virginia, Department of Molecular Physiology and Biological Physics , 1340 Jefferson Park Avenue, Charlottesville, VA 22908 , USA +1 434 243 6865 ; +1 434 243 2981 ; [email protected].

PMID: 26177814 PMCID: PMC4655606 DOI: 10.1517/17460441.2015.1061991

Abstract

INTRODUCTION: Macromolecular X-ray crystallography has been the primary methodology for determining the three-dimensional structures of proteins, nucleic acids and viruses. Structural information has paved the way for structure-guided drug discovery and laid the foundations for structural bioinformatics. However, X-ray crystallography still has a few fundamental limitations, some of which may be overcome and complemented using emerging methods and technologies in other areas of structural biology.

AREAS COVERED: This review describes how structural knowledge gained from X-ray crystallography has been used to advance other biophysical methods for structure determination (and vice versa). This article also covers current practices for integrating data generated by other biochemical and biophysical methods with those obtained from X-ray crystallography. Finally, the authors articulate their vision about how a combination of structural and biochemical/biophysical methods may improve our understanding of biological processes and interactions.

EXPERT OPINION: X-ray crystallography has been, and will continue to serve as, the central source of experimental structural biology data used in the discovery of new drugs. However, other structural biology techniques are useful not only to overcome the major limitation of X-ray crystallography, but also to provide complementary structural data that is useful in drug discovery. The use of recent advancements in biochemical, spectroscopy and bioinformatics methods may revolutionize drug discovery, albeit only when these data are combined and analyzed with effective data management systems. Accurate and complete data management is crucial for developing experimental procedures that are robust and reproducible.

Keywords: data management; hybrid methods; protein crystallography; reproducibility; structural data interpretation; target-based drug discovery

References

  1. Science. 2014 Mar 28;343(6178):1485-9 - PubMed
  2. Protein Sci. 2009 May;18(5):893-908 - PubMed
  3. Biochemistry. 2008 Dec 30;47(52):13974-84 - PubMed
  4. Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):125-32 - PubMed
  5. Infect Disord Drug Targets. 2009 Nov;9(5):507-17 - PubMed
  6. FEBS J. 2013 Nov;280(22):5705-36 - PubMed
  7. Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501 - PubMed
  8. Curr Opin Struct Biol. 2000 Oct;10(5):616-22 - PubMed
  9. Curr Opin Struct Biol. 2010 Oct;20(5):587-97 - PubMed
  10. Structure. 2012 Oct 10;20(10):1715-25 - PubMed
  11. Acta Crystallogr D Biol Crystallogr. 2005 Oct;61(Pt 10):1426-31 - PubMed
  12. Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):76-82 - PubMed
  13. Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3733-8 - PubMed
  14. Acta Crystallogr D Biol Crystallogr. 2013 Feb;69(Pt 2):150-67 - PubMed
  15. Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21 - PubMed
  16. ChemMedChem. 2012 Sep;7(9):1527-36 - PubMed
  17. Curr Opin Struct Biol. 2009 Oct;19(5):573-84 - PubMed
  18. Trends Biochem Sci. 2015 Jan;40(1):49-57 - PubMed
  19. Nature. 2014 Jan 30;505(7485):612-3 - PubMed
  20. Nature. 2015 Apr 23;520(7548):567-70 - PubMed
  21. Annu Rev Phys Chem. 2001;52:279-313 - PubMed
  22. Anal Biochem. 2004 Sep 1;332(1):153-9 - PubMed
  23. Acta Crystallogr D Biol Crystallogr. 2015 Sep;71(Pt 9):1965-79 - PubMed
  24. J Biomol NMR. 2011 Nov;51(3):227-33 - PubMed
  25. Protein Sci. 2014 Oct;23(10):1359-68 - PubMed
  26. Nat Methods. 2015 Apr;12(4):361-5 - PubMed
  27. J Am Chem Soc. 2014 Feb 5;136(5):1754-7 - PubMed
  28. J Cell Sci Suppl. 1991;14:23-6 - PubMed
  29. Drug Discov Today. 2014 Aug;19(8):1033-9 - PubMed
  30. Nat Protoc. 2014 Jan;9(1):156-70 - PubMed
  31. Contrast Media Mol Imaging. 2013 May-Jun;8(3):252-64 - PubMed
  32. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Feb 1;69(Pt 2):195-200 - PubMed
  33. Structure. 2011 Oct 12;19(10):1395-412 - PubMed
  34. Nat Methods. 2015 Apr;12(4):335-8 - PubMed
  35. J Struct Funct Genomics. 2013 Sep;14(3):77-90 - PubMed
  36. Acta Crystallogr D Biol Crystallogr. 2013 Aug;69(Pt 8):1540-52 - PubMed
  37. J Med Chem. 2005 Jan 27;48(2):403-13 - PubMed
  38. Adv Protein Chem Struct Biol. 2011;82:1-35 - PubMed
  39. Curr Opin Biotechnol. 2007 Dec;18(6):489-96 - PubMed
  40. J Mol Biol. 2009 Feb 20;386(2):520-30 - PubMed
  41. Infect Disord Drug Targets. 2009 Nov;9(5):459-74 - PubMed
  42. Nature. 2014 Oct 30;514(7524):550-3 - PubMed
  43. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):79-84 - PubMed
  44. J Inorg Biochem. 2008 Sep;102(9):1765-76 - PubMed
  45. Curr Comput Aided Drug Des. 2012 Sep;8(3):224-48 - PubMed
  46. Prog Nucl Magn Reson Spectrosc. 2015 Feb;84-85:14-32 - PubMed
  47. Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11211-6 - PubMed
  48. Acc Chem Res. 2013 Sep 17;46(9):2037-46 - PubMed
  49. J Med Chem. 2008 Aug 28;51(16):4986-99 - PubMed
  50. Cell. 2015 Feb 26;160(5):952-62 - PubMed
  51. J Am Chem Soc. 2011 Apr 20;133(15):5905-12 - PubMed
  52. Biochemistry. 2010 Feb 23;49(7):1486-94 - PubMed
  53. Annu Rev Med. 2002;53:595-614 - PubMed
  54. Nat Biotechnol. 2000 Oct;18(10):1105-8 - PubMed
  55. Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15370-5 - PubMed
  56. Curr Opin Struct Biol. 2014 Jun;26:39-43 - PubMed
  57. Methods Mol Biol. 2012;841:161-77 - PubMed
  58. Science. 2008 Aug 29;321(5893):1206-10 - PubMed
  59. Biomaterials. 2007 May;28(15):2380-92 - PubMed
  60. Transl Neurodegener. 2014 Oct 30;3(1):23 - PubMed
  61. Pharmacol Ther. 2015 Jul;151:121-40 - PubMed
  62. Annu Rev Biophys. 2013;42:265-87 - PubMed
  63. Anal Chem. 2010 Apr 1;82(7):2636-42 - PubMed
  64. Curr Opin Struct Biol. 2015 Apr;31:20-7 - PubMed
  65. Acta Crystallogr D Biol Crystallogr. 1999 Oct;55(Pt 10):1742-9 - PubMed
  66. Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21 - PubMed
  67. Methods Cell Biol. 2008;84:79-113 - PubMed
  68. Philos Trans R Soc Lond B Biol Sci. 2014 Jul 17;369(1647):20130590 - PubMed
  69. Ann Trop Med Parasitol. 1995 Dec;89 Suppl 1:23-30 - PubMed
  70. Cell. 2015 Apr 23;161(3):450-7 - PubMed
  71. Curr Protoc Immunol. 2004 Feb;Chapter 8:Unit 8.9 - PubMed
  72. Curr Opin Struct Biol. 2013 Jun;23(3):335-44 - PubMed
  73. Curr Opin Struct Biol. 2012 Jun;22(3):326-32 - PubMed
  74. Biol Cell. 2014 Oct;106(10):323-45 - PubMed
  75. J Struct Biol. 2003 Apr;142(1):56-65 - PubMed
  76. Curr Opin Drug Discov Devel. 2010 Jul;13(4):389-402 - PubMed
  77. Curr Opin Struct Biol. 2010 Oct;20(5):598-605 - PubMed
  78. Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66 - PubMed
  79. Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1405-9 - PubMed
  80. Science. 2014 Apr 25;344(6182):376-80 - PubMed
  81. Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):425-30 - PubMed
  82. FEBS J. 2008 Jan;275(1):1-21 - PubMed
  83. Nature. 2000 Apr 27;404(6781):960-7 - PubMed
  84. Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67 - PubMed
  85. Acta Crystallogr D Biol Crystallogr. 2011 Nov;67(Pt 11):915-9 - PubMed
  86. Expert Opin Drug Discov. 2011 Jan;6(1):17-32 - PubMed
  87. Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):136-53 - PubMed
  88. Nat Methods. 2008 Oct;5(10):853-4 - PubMed
  89. Nature. 2015 May 28;521(7553):545-9 - PubMed
  90. Methods Mol Biol. 2014;1140:1-25 - PubMed
  91. J Med Chem. 2006 Jan 26;49(2):656-63 - PubMed
  92. Curr Opin Struct Biol. 2011 Aug;21(4):517-22 - PubMed
  93. Expert Opin Drug Discov. 2011 Aug 1;6(8):771-782 - PubMed
  94. FEBS Lett. 2013 Apr 17;587(8):1036-45 - PubMed
  95. Protoplasma. 2014 Mar;251(2):417-27 - PubMed
  96. Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3407-12 - PubMed
  97. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17742-7 - PubMed
  98. Nat Methods. 2007 Dec;4(12):1019-21 - PubMed
  99. Expert Opin Drug Discov. 2014 Feb;9(2):125-37 - PubMed
  100. Curr Cancer Drug Targets. 2008 Feb;8(1):53-75 - PubMed
  101. Methods Mol Biol. 2014;1137:1-15 - PubMed
  102. ACS Comb Sci. 2013 Aug 12;15(8):387-92 - PubMed
  103. Nat Methods. 2014 Sep;11(9):927-30 - PubMed
  104. Biochim Biophys Acta. 2014 Jan;1838(1 Pt A):43-55 - PubMed
  105. Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22 - PubMed
  106. Pharmacol Ther. 2014 Sep;143(3):275-94 - PubMed
  107. Acta Crystallogr D Biol Crystallogr. 2005 Apr;61(Pt 4):449-57 - PubMed
  108. Curr Opin Struct Biol. 2007 Jun;17(3):347-53 - PubMed
  109. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):73-8 - PubMed
  110. Protein Sci. 2008 Feb;17(2):228-39 - PubMed
  111. Biophys J. 2008 Jul;95(1):1-9 - PubMed
  112. Nature. 2010 Jun 17;465(7300):891-6 - PubMed
  113. Protein Sci. 2007 Jun;16(6):1069-86 - PubMed

Substances

MeSH terms

Publication Types

Grant support